Pahr Therapeutics
PrivateLast Round
Seed
Jul 28, 2025
Total Funding Raised
$14M
Company Overview
Pahr Therapeutics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Seed round in July 2025.
Pahr Therapeutics is a clinical-stage biotechnology company developing novel therapies for pulmonary arterial hypertension (PAH).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pahr Therapeutics Comparables
Compare Pahr Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zymedi | 85% | |
| tiakis Biotech AG | 83% | |
| Diagonal Therapeutics | 83% |
For institutional investors. Book with your work email.
Pahr Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Pahr Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| UTEC (The University of Tokyo Edge Capital Partners) | Seed |
| AN Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2025
$14M round led by AN Venture Partners, RA Capital Management, and UTEC.
For institutional investors. Book with your work email.
Pahr Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pahr Therapeutics's valuation, stock price, and market status.
Is Pahr Therapeutics a public or private company?
Pahr Therapeutics is a private company.
What is the current stock price of Pahr Therapeutics?
Pahr Therapeutics is a private company, so its shares have no public market price. Caplight tracks Pahr Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pahr Therapeutics worth (valuation)?
Valuation information for Pahr Therapeutics is not publicly available.
Can I buy Pahr Therapeutics stock?
Pahr Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pahr Therapeutics's last funding round?
Pahr Therapeutics's most recent funding round was Seed on July 28, 2025.
Who are the main investors in Pahr Therapeutics?
Key investors in Pahr Therapeutics include RA Capital Management, UTEC (The University of Tokyo Edge Capital Partners), AN Venture Partners.
Will Pahr Therapeutics IPO soon?
No public IPO plans have been announced for Pahr Therapeutics.
How can I track Pahr Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Pahr Therapeutics's shares on secondary markets.